{"id":3645,"date":"2020-10-13T13:18:03","date_gmt":"2020-10-13T11:18:03","guid":{"rendered":"https:\/\/www.ab-science.com\/masivet\/"},"modified":"2026-09-30T10:38:52","modified_gmt":"2026-09-30T08:38:52","slug":"masivet","status":"publish","type":"page","link":"https:\/\/ab-science.excalibra.com\/fr\/masivet\/","title":{"rendered":"Masivet\u00ae"},"content":{"rendered":"

[vc_row full_width=\u00a0\u00bbstretch_row_content_no_spaces\u00a0\u00bb el_class=\u00a0\u00bbabp-hero\u00a0\u00bb][vc_column][vc_column_text]<\/p>\n

\n

M\u00e9dicament v\u00e9t\u00e9rinaire<\/p>\n

Masivet\u00ae.<\/span><\/h1>\n

Une th\u00e9rapie cibl\u00e9e d\u00e9di\u00e9e \u00e0 la prise en charge de certaines tumeurs \u00e0 mastocytes chez le chien.<\/p>\n<\/div>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=\u00a0\u00bbstretch_row\u00a0\u00bb el_class=\u00a0\u00bbabp-section\u00a0\u00bb][vc_column][vc_column_text]<\/p>\n

\n

Pr\u00e9sentation<\/p>\n

Une approche cibl\u00e9e en oncologie v\u00e9t\u00e9rinaire.<\/span><\/h2>\n<\/div>\n

[\/vc_column_text][vc_row_inner gap=\u00a0\u00bb24″ equal_height=\u00a0\u00bbyes\u00a0\u00bb el_class=\u00a0\u00bbab-masivet-overview abp-shell\u00a0\u00bb][vc_column_inner width=\u00a0\u00bb1\/2″ el_class=\u00a0\u00bbab-masivet-copy\u00a0\u00bb][vc_column_text]<\/p>\n

Les tumeurs canc\u00e9reuses \u00e0 mastocytes (TCM) sont les tumeurs cutan\u00e9es les plus courantes chez les chiens et ayant souvent un mauvais pronostic.<\/p>\n

Masivet\u00ae est un m\u00e9dicament hautement sp\u00e9cifique, ciblant les voies biologiques cl\u00e9s du d\u00e9veloppement et de la croissance des TCM.<\/p>\n

Masivet\u00ae a \u00e9t\u00e9 approuv\u00e9 en 2008 par l\u2019Agence europ\u00e9enne du m\u00e9dicament (EMA) en m\u00e9decine v\u00e9t\u00e9rinaire pour le traitement des TCM non op\u00e9rables chez le chien (grade 2 ou 3) avec pr\u00e9sence d\u2019une forme mut\u00e9e du r\u00e9cepteur c-kit.<\/p>\n

[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00a0\u00bb1\/2″ el_class=\u00a0\u00bbab-masivet-visual\u00a0\u00bb][vc_single_image image=\u00a0\u00bb11368″ img_size=\u00a0\u00bbfull\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row full_width=\u00a0\u00bbstretch_row\u00a0\u00bb el_class=\u00a0\u00bbabp-section abp-section–soft ab-masivet-history\u00a0\u00bb][vc_column][vc_column_text]<\/p>\n

\n

Depuis 2008<\/p>\n

Pr\u00e8s de vingt ans d\u2019exploitation commercial du Masivet\u00ae.<\/h2>\n
\n
\n

Autorisation europ\u00e9enne<\/span><\/p>\n

En 2028, AB Science c\u00e9l\u00e9brera le 20\u00e8 anniversaire de l\u2019autorisation de mise sur le march\u00e9 de Masivet\u00ae.<\/p>\n<\/div>\n

\n

Utilisation cibl\u00e9e<\/span><\/p>\n

Depuis son approbation, Masivet a \u00e9t\u00e9 utilis\u00e9 avec succ\u00e8s comme une approche cibl\u00e9e de la gestion du cancer en m\u00e9decine v\u00e9t\u00e9rinaire et des dizaines de milliers de cas ont \u00e9t\u00e9 trait\u00e9s avec Masivet\u00ae.<\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=\u00a0\u00bbstretch_row\u00a0\u00bb el_class=\u00a0\u00bbabp-section ab-masivet-highlight\u00a0\u00bb][vc_column][vc_column_text]<\/p>\n

\n

Une avanc\u00e9e v\u00e9t\u00e9rinaire<\/p>\n

Masivet\u00ae a fait entrer l\u2019oncologie v\u00e9t\u00e9rinaire dans l\u2019\u00e8re moderne en lui donnant acc\u00e8s \u00e0 des th\u00e9rapies cibl\u00e9es.<\/h2>\n

Les r\u00e9sultats de Masivet\u00ae en m\u00e9decine v\u00e9t\u00e9rinaire au cours des deux derni\u00e8res d\u00e9cennies sont des preuves encourageantes pour le d\u00e9veloppement clinique de ce compos\u00e9 en m\u00e9decine humaine.<\/p>\n

Consulter les caract\u00e9ristiques du produit<\/a>Contacter l\u2019\u00e9quipe Masivet<\/a><\/div>\n<\/div>\n

[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row full_width=\u00a0\u00bbstretch_row_content_no_spaces\u00a0\u00bb el_class=\u00a0\u00bbabp-hero\u00a0\u00bb][vc_column][vc_column_text] M\u00e9dicament v\u00e9t\u00e9rinaire Masivet\u00ae. Une th\u00e9rapie cibl\u00e9e d\u00e9di\u00e9e \u00e0 la prise en charge de certaines tumeurs \u00e0 mastocytes chez le chien. [\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=\u00a0\u00bbstretch_row\u00a0\u00bb el_class=\u00a0\u00bbabp-section\u00a0\u00bb][vc_column][vc_column_text] Pr\u00e9sentation Une approche cibl\u00e9e en oncologie v\u00e9t\u00e9rinaire. [\/vc_column_text][vc_row_inner gap=\u00a0\u00bb24″ equal_height=\u00a0\u00bbyes\u00a0\u00bb el_class=\u00a0\u00bbab-masivet-overview abp-shell\u00a0\u00bb][vc_column_inner width=\u00a0\u00bb1\/2″ el_class=\u00a0\u00bbab-masivet-copy\u00a0\u00bb][vc_column_text] Les tumeurs canc\u00e9reuses \u00e0 mastocytes (TCM) sont les tumeurs cutan\u00e9es les plus courantes chez les…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3645","page","type-page","status-publish","hentry","description-off"],"yoast_head":"\nMasivet\u00ae – AB Science<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Masivet\u00ae\" \/>\n<meta property=\"og:description\" content=\"[vc_row full_width=\u00a0\u00bbstretch_row_content_no_spaces\u00a0\u00bb el_class=\u00a0\u00bbabp-hero\u00a0\u00bb][vc_column][vc_column_text] M\u00e9dicament v\u00e9t\u00e9rinaire Masivet\u00ae. Une th\u00e9rapie cibl\u00e9e d\u00e9di\u00e9e \u00e0 la prise en charge de certaines tumeurs \u00e0 mastocytes chez le chien. [\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=\u00a0\u00bbstretch_row\u00a0\u00bb el_class=\u00a0\u00bbabp-section\u00a0\u00bb][vc_column][vc_column_text] Pr\u00e9sentation Une approche cibl\u00e9e en oncologie v\u00e9t\u00e9rinaire. [\/vc_column_text][vc_row_inner gap=\u00a0\u00bb24″ equal_height=\u00a0\u00bbyes\u00a0\u00bb el_class=\u00a0\u00bbab-masivet-overview abp-shell\u00a0\u00bb][vc_column_inner width=\u00a0\u00bb1\/2″ el_class=\u00a0\u00bbab-masivet-copy\u00a0\u00bb][vc_column_text] Les tumeurs canc\u00e9reuses \u00e0 mastocytes (TCM) sont les tumeurs cutan\u00e9es les plus courantes chez les…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ab-science.excalibra.com\/fr\/masivet\/\" \/>\n<meta property=\"og:site_name\" content=\"AB Science\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-30T08:38:52+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/masivet\\\/\",\"url\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/masivet\\\/\",\"name\":\"Masivet\u00ae – AB Science\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/#website\"},\"datePublished\":\"2020-10-13T11:18:03+00:00\",\"dateModified\":\"2026-09-30T08:38:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/masivet\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/masivet\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/masivet\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Masivet\u00ae\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/\",\"name\":\"AB Science\",\"description\":\"Masitinib and AB8939 \u2013 Two compounds with breakthrough mechanism of action\",\"publisher\":{\"@id\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/#organization\",\"name\":\"AB Science\",\"url\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/logo_ab-science-wh120.png\",\"contentUrl\":\"https:\\\/\\\/www.ab-science.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/logo_ab-science-wh120.png\",\"width\":120,\"height\":120,\"caption\":\"AB Science\"},\"image\":{\"@id\":\"https:\\\/\\\/ab-science.excalibra.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ab-science\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Masivet\u00ae – AB Science","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Masivet\u00ae","og_description":"[vc_row full_width=\u00a0\u00bbstretch_row_content_no_spaces\u00a0\u00bb el_class=\u00a0\u00bbabp-hero\u00a0\u00bb][vc_column][vc_column_text] M\u00e9dicament v\u00e9t\u00e9rinaire Masivet\u00ae. Une th\u00e9rapie cibl\u00e9e d\u00e9di\u00e9e \u00e0 la prise en charge de certaines tumeurs \u00e0 mastocytes chez le chien. [\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=\u00a0\u00bbstretch_row\u00a0\u00bb el_class=\u00a0\u00bbabp-section\u00a0\u00bb][vc_column][vc_column_text] Pr\u00e9sentation Une approche cibl\u00e9e en oncologie v\u00e9t\u00e9rinaire. [\/vc_column_text][vc_row_inner gap=\u00a0\u00bb24″ equal_height=\u00a0\u00bbyes\u00a0\u00bb el_class=\u00a0\u00bbab-masivet-overview abp-shell\u00a0\u00bb][vc_column_inner width=\u00a0\u00bb1\/2″ el_class=\u00a0\u00bbab-masivet-copy\u00a0\u00bb][vc_column_text] Les tumeurs canc\u00e9reuses \u00e0 mastocytes (TCM) sont les tumeurs cutan\u00e9es les plus courantes chez les…","og_url":"https:\/\/ab-science.excalibra.com\/fr\/masivet\/","og_site_name":"AB Science","article_modified_time":"2026-09-30T08:38:52+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ab-science.excalibra.com\/fr\/masivet\/","url":"https:\/\/ab-science.excalibra.com\/fr\/masivet\/","name":"Masivet\u00ae – AB Science","isPartOf":{"@id":"https:\/\/ab-science.excalibra.com\/fr\/#website"},"datePublished":"2020-10-13T11:18:03+00:00","dateModified":"2026-09-30T08:38:52+00:00","breadcrumb":{"@id":"https:\/\/ab-science.excalibra.com\/fr\/masivet\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ab-science.excalibra.com\/fr\/masivet\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ab-science.excalibra.com\/fr\/masivet\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ab-science.excalibra.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Masivet\u00ae"}]},{"@type":"WebSite","@id":"https:\/\/ab-science.excalibra.com\/fr\/#website","url":"https:\/\/ab-science.excalibra.com\/fr\/","name":"AB Science","description":"Masitinib and AB8939 \u2013 Two compounds with breakthrough mechanism of action","publisher":{"@id":"https:\/\/ab-science.excalibra.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ab-science.excalibra.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ab-science.excalibra.com\/fr\/#organization","name":"AB Science","url":"https:\/\/ab-science.excalibra.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ab-science.excalibra.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ab-science.com\/wp-content\/uploads\/2020\/11\/logo_ab-science-wh120.png","contentUrl":"https:\/\/www.ab-science.com\/wp-content\/uploads\/2020\/11\/logo_ab-science-wh120.png","width":120,"height":120,"caption":"AB Science"},"image":{"@id":"https:\/\/ab-science.excalibra.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/ab-science\/"]}]}},"_links":{"self":[{"href":"https:\/\/ab-science.excalibra.com\/fr\/wp-json\/wp\/v2\/pages\/3645","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ab-science.excalibra.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ab-science.excalibra.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ab-science.excalibra.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ab-science.excalibra.com\/fr\/wp-json\/wp\/v2\/comments?post=3645"}],"version-history":[{"count":8,"href":"https:\/\/ab-science.excalibra.com\/fr\/wp-json\/wp\/v2\/pages\/3645\/revisions"}],"predecessor-version":[{"id":11887,"href":"https:\/\/ab-science.excalibra.com\/fr\/wp-json\/wp\/v2\/pages\/3645\/revisions\/11887"}],"wp:attachment":[{"href":"https:\/\/ab-science.excalibra.com\/fr\/wp-json\/wp\/v2\/media?parent=3645"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}